Medical Foods Global Market Report 2026

Medical foods are foods formulated to be consumed orally under the supervision of a physician and are intended to meet specific dietary requirements. They are designed to help manage existing diseases or medical conditions through targeted nutritional support. Medical foods are exempt from standard labeling requirements related to nutrition content and health claims.

The main types of medical foods include pills, powders, and others. Medical food pills are small pellets or tablets, often coated, that are taken by swallowing whole or by chewing. These pills are specially developed to address the nutritional needs of patients with various medical conditions, such as depression, attention-deficit/hyperactivity disorder (ADHD), and others. They are used in the treatment of Alzheimer's disease, diabetic neuropathy, nutritional deficiencies, ADHD, and other conditions, and are distributed through online, retail, and institutional sales channels.

Tariffs have influenced the medical foods market by increasing import costs for raw ingredients and specialized formulations, which affects production expenses and supply chain efficiency. Segments like powder formulations and pills, particularly in regions such as North America and Europe, are most impacted due to reliance on international sourcing. While tariffs can increase costs, they may also encourage local manufacturing and innovation in cost-effective formulations, boosting domestic production and potentially creating more resilient supply chains.

The medical foods market research report is one of a series of new reports from The Business Research Company that provides medical foods market statistics, including medical foods industry global market size, regional shares, competitors with a medical foods market share, detailed medical foods market segments, market trends and opportunities, and any further data you may need to thrive in the medical foods industry. This medical foods market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical foods market size has grown strongly in recent years. It will grow from $24.37 billion in 2025 to $26.26 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing geriatric population, growing awareness of therapeutic nutrition, advancements in medical research, expansion of hospital & clinical infrastructure.

The medical foods market size is expected to see strong growth in the next few years. It will grow to $35.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to technological integration in nutritional monitoring, growth of online & institutional distribution channels, increasing adoption of disease-specific medical foods, rising investments in r&d for functional ingredients, expansion of home healthcare services. Major trends in the forecast period include personalized nutritional solutions, disease-specific formulations, regulatory compliance & safety standards, functional ingredients innovation, growing home healthcare adoption.

The growing geriatric population is significantly contributing to the expansion of the medical foods market. At the molecular and cellular level, aging results from the accumulation of various forms of biomolecular damage over time. This process leads to a gradual decline in functional capacity, an increased susceptibility to disease, and ultimately death. These age-related changes do not occur in a linear or continuous manner and are only loosely associated with an individual's chronological age. As people age, their reliance on specific nutritional support increases, particularly medical foods, to help manage chronic and age-related health conditions. For example, in October 2025, the World Health Organization (WHO), a Switzerland-based agency responsible for global public health, reported that by 2030, one in six people worldwide will be aged 60 years or older. By 2050, the global population of individuals aged 60 years and above is expected to double, reaching 2.1 billion. Consequently, the rising geriatric population is expected to drive the growth of the medical foods market.

Major companies operating in the medical foods market are concentrating on the development of innovative offerings, such as plant-based, nutritionally complete oral medical nutrition drinks, to address the growing demand for clinically appropriate, lactose-free, allergy-friendly, and environmentally sustainable nutrition options for patients under medical supervision. Plant-based medical nutrition drinks utilize non-dairy protein sources, such as pea and soy, to deliver complete macro- and micronutrient profiles comparable to conventional dairy-based formulations, while enhancing gastrointestinal tolerance and suitability for vegan and milk-allergic patients. For example, in January 2023, Nutricia, a Netherlands-based medical nutrition company, introduced Fortimel PlantBased Energy, its first plant-based Food for Special Medical Purposes (FSMP) designed for the dietary management of disease-related malnutrition. The product provides energy-dense, nutritionally complete nutrition using a pea-and-soy protein blend, supports patients with cow's-milk protein allergy, is suitable for vegan and flexitarian diets, and is offered in two flavors to improve patient adherence in both clinical and home-care settings.

In July 2023, Pentec Health Inc., a US-based pharmaceutical products and services company, acquired ZOIA Pharma for an undisclosed amount. This acquisition is intended to improve access to a broad portfolio of medical foods for patients with rare conditions, including individuals with phenylketonuria (PKU), who will now have access to the latest PKU GOLIKE family of medical food products. The transaction highlights Pentec's commitment to expanding its medical food offerings into emerging and underserved areas of clinical nutrition while strengthening its position as a complex care provider. ZOIA Pharma is a US-based medical food company.

Major companies operating in the medical foods market are Nestle SA, Danone SA, Fresenius Kabi AG, Mead Johnson & Company LLC, Primus Pharmaceuticals Inc., Abbott Nutrition Inc., Accera Inc., Ajinomoto Cambrooke Inc., Applied Food Sciences Inc., Cambrooke Therapeutics Inc., Danone Nutricia North America Inc., Health and Happiness (H&H) Group Limited, RFI Ingredients LLC, Solace Nutrition LLC, Targeted Medical Pharma Inc., VAYA Pharma Inc., Baxter Healthcare Corporation, Braun Melsungen AG, DuPont Nutrition & Biosciences, Enteral Nutrition Holdings Inc., Fresenius Medical Care AG & Co. KGaA, Nutricia North America Inc., Otsuka Pharmaceutical Co. Ltd., Koninklijke DSM NV, Total Parenteral Nutrition Solutions Inc.

North America was the largest region in the medical foods market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical foods market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical foods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical foods market consists of sales of oral rehydration products, amino acids, and probiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Foods Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical foods market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical foods ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical foods market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Pills; Powder; Other Types
• 2) By Application: Alzheimer's Disease; Diabetic Neuropathy; Nutritional Deficiency; ADHD; Other Applications
• 3) By Sales Channel: Retail Sales; Online Sales; Institutional Sales
• Subsegments:
• 1) By Pills: Tablets; Capsules; Softgels
• 2) By Powder: Nutritional Powders; Fiber Powders
• 3) By Other Types: Liquid Formulations; Ready-To-Drink Products; Functional Bars And Snacks
• Companies Mentioned: Nestle SA; Danone SA; Fresenius Kabi AG; Mead Johnson & Company LLC; Primus Pharmaceuticals Inc.; Abbott Nutrition Inc.; Accera Inc.; Ajinomoto Cambrooke Inc.; Applied Food Sciences Inc.; Cambrooke Therapeutics Inc.; Danone Nutricia North America Inc.; Health and Happiness (H&H) Group Limited; RFI Ingredients LLC; Solace Nutrition LLC; Targeted Medical Pharma Inc.; VAYA Pharma Inc.; Baxter Healthcare Corporation; Braun Melsungen AG; DuPont Nutrition & Biosciences; Enteral Nutrition Holdings Inc.; Fresenius Medical Care AG & Co. KGaA; Nutricia North America Inc.; Otsuka Pharmaceutical Co. Ltd.; Koninklijke DSM NV; Total Parenteral Nutrition Solutions Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.